Skip to content

Investor Relations

Page Path 'Breadcrumb':

Investor Relations

Corporate Profile

Ardea Biosciences, Inc. (NASDAQ: RDEA), headquartered in San Diego, California, is a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV).

Stock Quote
RDEA (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$19.95
Change (%) Stock is Up 0.45 (2.31%)
Volume222,927
Data as of 07/30/10 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Presentations
Ardea Company Update, June 29 2010

Recent NewsMore News >>
DateTitle 
06/21/10Ardea Biosciences to Present at the Fifth Annual Piper Jaffray Europe Conference
SAN DIEGO, June 21, 2010 /PRNewswire via COMTEX/ --Ardea Biosciences, Inc. (Nasdaq: RDEA) announced today that Barry D. Quart, PharmD, president and chief executive officer, will present at the Fifth Annual Piper Jaffray Europe Conference in London, England. Dr. Quart is scheduled to present at 11:30 a.m. BST on Tuesday, June 22, 2010. This presentation will be webcast and can be accessed on the Investor Relations section of Ardea's website at www.ardeabio.com. Please connect to Ardea's websi... 
Printer Friendly Version
06/18/10Positive Phase 2 Data on RDEA594, Ardea Biosciences' Lead Product Candidate for the Treatment of Hyperuricemia and Gout, Presented at the Annual European Congress of Rheumatology
New Data from Five Clinical Studies Reinforce RDEA594's Robust Efficacy and Encouraging Safety Profile ROME, June 18, 2010 /PRNewswire via COMTEX/ --Ardea Biosciences, Inc. (Nasdaq: RDEA) today announced that additional positive data from its Phase 2 program for RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, are being presented at the Annual European Congress of Rheumatology hosted by the European League Against Rheumatism (EULAR) in Rome, Italy. RDEA594, a ... 
Printer Friendly Version
06/07/10Ardea Biosciences to Present at the Jefferies 2010 Global Life Sciences Conference
SAN DIEGO, June 7, 2010 /PRNewswire via COMTEX/ --Ardea Biosciences, Inc. (Nasdaq: RDEA) announced today that Barry D. Quart, PharmD, president and chief executive officer, will present at the Jefferies 2010 Global Life Sciences Conference in New York, New York. Dr. Quart is scheduled to present at 2:00 p.m. EDT on Tuesday, June 8, 2010. This presentation will be webcast and can be accessed on the Investor Relations section of Ardea's website at http://www.ardeabio.com/. Please connect to Arde... 
Printer Friendly Version
05/14/10Ardea Biosciences to Present at Two Upcoming Investor Conferences
SAN DIEGO, May 14, 2010 /PRNewswire via COMTEX/ --Ardea Biosciences, Inc. (Nasdaq: RDEA) announced today that Barry D. Quart, PharmD, president and chief executive officer, will present at the following upcoming investor conferences: Brean Murray, Carret & Co. 2010 Life Sciences Summit in New York, New York. Presentation: 9:30 a.m. EDT on Monday, May 17, 2010. Citi 2010 Healthcare Conference in New York, New York. Presentation: 1:30 p.m. EDT on Thursday, May 27, 2010. This presentatio... 
Printer Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.